We are live on ! Find out more
FEED

ENvue Medical Inc

7 hedge funds and large institutions have $204K invested in ENvue Medical Inc in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0%0.03% (+0.03%)

50% less funds holding

Funds holding: 147 (-7)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

66% less capital invested

Capital invested by funds: $593K → $204K (-$389K)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
9
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q1 2023 in Review

7 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2023, worth a combined $204K — down 66% from $593K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of FEED and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $15.6K. The largest seller was AWM Investment Company, exiting entirely with an estimated $225K sold.

  • 7 institutional investors held ENvue Medical Inc (FEED) as of Q1 2023, down from 14 in Q4 2022.
  • Funds reported $204K of ENvue Medical Inc stock for Q1 2023, down 66% quarter-over-quarter.
  • 2 funds opened new ENvue Medical Inc positions in Q1 2023 and 9 closed out, a net change of -7 holders.
  • The largest ENvue Medical Inc buyer in Q1 2023 was UBS Group, an estimated $15.6K added.
  • The largest ENvue Medical Inc seller in Q1 2023 was AWM Investment Company, an estimated $225K sold.

Based on aggregated 13F filings for Q1 2023.